Proteases of the caspase family are implicated in mammalian apoptosis and constitute a protease cascade. We characterized caspase-4 (TX/ICH-2/ICE rel II) and caspase-5 (ICE rel III/TY), which are most closely related to caspase-1 (ICE) among the caspase family. Although overexpression of caspase-4 and caspase-5 induced apoptosis, confirming previous observations, this apoptosis was not inhibited by a caspase-1-specific tetrapeptide inhibitor (Ac-YVAD-CHO), suggesting that caspase-4 and caspase-5 have different substrate specificities from caspase-1 and also that caspase-4-and caspase-5-induced apoptosis is not mediated by caspase-1. CrmA, a cowpox virus-derived caspase-1 inhibitor that prevents apoptosis induced by various stimuli, was cleaved by caspase-4 and caspase-5, and inhibited their proteolytic activity as assessed by cleavage of pro-caspase-3 (pro-CPP32/Yama/apopain). Thus, caspase-4 and caspase-5 are CrmA-inhibitable proteases like caspase-1 and might be involved in apoptosis.
Introduction
Apoptosis, or programmed cell death, is a fundamental process crucial to morphogenesis and the maintenance of homeostasis in both vertebrates and invertebrates. Genetic studies in the nematode Caenorhabditis elegans have led to the isolation of genes, including ced-3, ced-4 and ced-9, that are involved in programmed cell death (Yuan and Horvitz, 1990; Hengartner et al, 1992) . ced-3 and ced-4 are required for such cell death to occur. ced-3 encodes a protein that is similar to interleukin-1b (IL-1b)-converting enzyme (ICE), a cysteine protease that cleaves the inactive 31 kDa precursor of IL-1b to generate the active cytokine (Thornberry et al, 1992; Yuan et al, 1993) . Ten proteins homologous to ICE (caspase-1) have been identified in mammals and are classified into three subfamilies, caspase-1-, caspase-3 (CPP32/Yama/apopain)-, and caspase-2 (NEDD2/ICH-1)-like proteases, based on their structures . The caspase-1-like subfamily includes caspase-1 (Thornberry et al, 1992) , caspase-4 (TX/ICH-2/ICE rel II) (Faucheu et al, 1995; Kamens et al, 1995; Munday et al, 1995) , and caspase-5 (ICE rel III/TY) (Munday et al, 1995; Faucheu et al, 1996) . The caspases have been suggested to constitute a protease cascade (Martin and Green, 1995; Enari et al, 1996; Shimizu et al, 1996) . Among the caspase family, caspase-1(-like) and caspase-3(-like) proteases have been implicated in physiological cell death, based upon the inhibition of cell death by tetrapeptide inhibitors of caspase-1 and caspase-3 (Los et al, 1995; Milligan et al, 1995; Nicholson et al, 1995; Enari et al, 1996; Chen et al, 1996; Jacobson et al, 1996; Schlegel et al, 1996; Hasegawa et al, 1996; Dubrez et al, 1996) . Studies of a shorter isoform of caspase-2 have also revealed its involvement in cell death (Wang et al, 1994) . However, roles of other members of this family in cell death remain to be elucidated. Since apoptosis induced by a variety of stimuli is inhibited by baculovirus p35 (Clem et al, 1991; Rabizadeh et al, 1993; Hay et al, 1994; Sugimoto et al, 1994; Beidler et al, 1995) , which inhibits the activities of caspases (Xue and Horvitz, 1995; Bump et al, 1995) , and by a cowpox virus-derived caspase-1 inhibitor, CrmA (Pickup et al, 1986; Ray et al, 1992; Gagliardini et al, 1994; Tewari and Dixit, 1995; Los et al, 1995; Enari et al, 1995; Tewari et al, 1995b; Li et al, 1996) , it would be interesting to identify CrmA-inhibitable members of the caspase family.
In the present study, we characterized caspase-4 and caspase-5, which are most closely related to caspase-1 among the caspase family, and showed that these two proteases have similar substrate preferences and are both CrmA-inhibitable. and caspase-5 cDNAs in frame with the E. coli lacZ gene and placed the fused gene under the control of the chicken b-actin promoter in pcas-4-lacZ and pcas-5-lacZ, respectively. We also used constructs of the fusion gene of the caspase-1 and caspase-2 L cDNAs with the lacZ gene, pcas-1-lacZ and pbactH37Z (Wang et al, 1994) , respectively. The fusion genes were transfected into Rat-1 cells and their expression was examined with the X-Gal reaction. Most blue Rat-1 cells (XGal-positive) transfected with the lacZ gene alone were flat and well attached to the plates (data not shown). In contrast, most blue cells transfected with pcas-4-lacZ and pcas-5-lacZ contained round or small membrane-bound fragments representing apoptotic bodies, similar to those in cells transfected with pcas-1-lacZ and pbactH37Z. These results indicate that overexpression of caspase-4 and caspase-5 proteins induces Rat-1 cells to undergo apoptosis, confirming previous observations (Faucheu et al, 1995; Kamens et al, 1995; Munday et al, 1995) . The tetrapeptide caspase-1 inhibitor Ac-YVAD-CHO (Thornberry et al, 1992) effectively blocked caspase-1-induced apoptosis in a concentrationdependent manner, whereas caspase-4-, caspase-5-and caspase-2 L -induced apoptosis was not significantly inhibited ( Figure 1 ). These findings suggest that caspase-4 and caspase-5 have different substrate specificities from caspase-1 and also that caspase-4-, caspase-5-, and caspase-2 L -induced apoptosis are not mediated by caspase-1.
Caspase-4 and caspase-5 show similar substrate preferences in the in vitro cleavage assay
We compared the substrate preferences of caspase-4 and caspase-5 with cowpox virus CrmA, baculovirus p35, and procaspase-3 as potential substrates using recombinant proteases and in vitro translated 35 S-labeled substrates. The results are summarized in Table 1 . Caspase-4 and caspase-5 Figure 1 Effect of Ac-YVAD-CHO on caspase-1-, caspase-4-, caspase-5-, and caspase-2 L -induced apoptosis. One day after plating Rat-1 cells at a density of 2610 5 in each well of 6-well dishes, 1.0 mg of the indicated DNA constructs was transfected. pbactH37Z is the caspase-2 L -expressing construct (Wang et al, 1994) . The cells were incubated for 3 hr in serumfree medium containing DNA and lipofectamine, washed with serum-free medium, cultured in medium containing 10% FBS and the indicated concentrations of inhibitor (Ac-YVAD-CHO) for an additional 20 h and stained with X-Gal. 35 S-labeled CrmA protein was incubated with the indicated amounts of purified caspase-4, caspase-5, or caspase-3 for 3.5 h and reaction products were analyzed by 15% SDS ± PAGE. The His-p33 band corresponds to the Histagged amino-terminal cleavage product resulting from cleavage at Asp-304. The 5 kDa carboxy-terminal cleavage product was not seen because it contains no methionine residues. (B) Cleavage of baculovirus p35 by caspase-4, caspase-5, and caspase-3. 35 S-labeled p35 protein was incubated with purified caspase-4, caspase-5, or caspase-3 and the reaction products were analyzed as described in (A). The p25 band corresponds to the carboxy-terminal cleavage product resulting from cleavage at Asp-87. The His-p10 bands correspond to the His-tagged amino-terminal cleavage product. (C) Cleavage of pro-caspase-3 by caspase-4, caspase-5, and caspase-3.
35 Slabeled mutant pro-caspase-3 protein was incubated with purified caspase-4, caspase-5, or caspase-3 and the reaction products were analyzed as described in (A). The p17 and p12 bands correspond to two subunits of active caspase-3. The His-prop17 bands may be the His-tagged prodomain with the p17 subunit resulting from cleavage at Asp-175. The p19 band may be the amino-terminal cleavage product resulting from cleavage at Asp-9 and proteases showed a preference for CrmA rather than p35 as a substrate, whereas caspase-3 effectively cleaved p35 and only poorly cleaved CrmA (Figure 2a and b) . As shown in Figure 2c , purified recombinant caspase-3 cleaved procaspase-3 bearing active site mutations at both p17 and p12 (subunits of the active enzyme) to generate p12 and p17, confirming previous observations Xue et al, 1996) . Purified recombinant caspase-4 and caspase-5 also cleaved pro-caspase-3 to generate p12 and pro-p17 ( Figure  2c ). The in vitro cleavage of CrmA, baculovirus p35, and mutant pro-caspase-3 by caspase-4, caspase-5, and caspase-3 was dependent on the concentration of the respective protease. Lysates of bacteria expressing the respective proteases cleaved the substrates, but not lysates of bacteria with a control vector (data not shown), indicating that cleavage was not due to contaminating bacterial proteases. These data show that caspase-4 and caspase-5 have a similar substrate preference for CrmA and p35.
CrmA inhibits cleavage of pro-caspase-3 by caspase-4 and caspase-5
Detection of the cleavage of CrmA by caspase-4 and caspase-5 led us to examine whether CrmA directly inhibits the proteolytic activities of caspase-4 and caspase-5 using the in vitro cleavage assay. As shown in Figure 3 , CrmA effectively inhibited the cleavage of pro-caspase-3 by recombinant caspase-4 and caspase-5, indicating that caspase-4 and caspase-5 are CrmA-inhibitable proteases.
Caspase-4-and caspase-5-induced apoptosis is inhibited by CrmA
To further confirm the inhibitory effect of CrmA on caspase-4 and caspase-5 in vivo, Rat-1 cells were cotransfected with lacZ fusion plasmids (pcas-1-lacZ, pcas-4-lacZ, pcas-5-lacZ, and pbactH37Z) together with a crmA expression construct (pCAG-crmA). As shown in Figure 4 , apoptosis induced by overexpression of caspase-4 and caspase-5 was inhibited by CrmA as effectively as caspase-1-induced apoptosis. In contrast, caspase-2 L -induced apoptosis was not affected by CrmA, confirming the previous observation (Wang et al, 1994) .
Discussion
The implication of caspase-1 in physiological cell death is based upon the prevention of apoptosis by inhibitors of the protease, including a tetrapeptide caspase-1 inhibitor Ac-YVAD-CHO (Los et al, 1995; Milligan et al, 1995; Enari et al, 1996; Chen et al, 1996) , that was prepared based on the cleavage site in proIL-1b (Thornberry et al, 1992) . However, it has not previously been determined whether Ac-YVAD-CHO only inhibits caspase-1. We showed that apoptosis induced by caspase-4 and caspase-5, which are most closely related to caspase-1, was not inhibited by Ac-YVAD-CHO, a finding consistent with the previous observation that caspase-4 and caspase-5 could not cleave proIL-1b (Faucheu et al, 1995 (Faucheu et al, , 1996 Munday et al, 1995) . Although the Ki of caspase-1 inhibition by Ac-YVAD-CHO is 51 nM, caspase-1-induced apoptosis is only partially inhibited by 100 mM inhibitor. This is probably due to poor cell permeability of the tetrapeptide inhibitor. Thus, the available data suggest that Ac-YVAD-CHO is a quite specific inhibitor of caspase-1 itself.
His-pro-caspase-3
His-prop17 p12 caspase-4 caspase-5 0 0.2 1 5 0 0.2 1 5 µg Figure 3 CrmA-mediated inhibition of the cleavage of pro-caspase-3 by caspase-4 and caspase-5. 35 S-labeled mutant pro-caspase-3 protein was incubated with 5 mg of purified caspase-4 and caspase-5 and the indicated amounts of purified CrmA for 3.5 h after which the reaction products were analyzed by 15% SDS ± PAGE. Effects of CrmA on caspase-1-, caspase-4-, caspase-5-and caspase-2 L -induced apoptosis. One day after plating Rat-1 cells at a density of 2610 5 in each well of 6-well dishes, 0.1 mg of the indicated plasmids and various amount of pCAG-crmA or pUC-CAGGS were transfected in a total of 1.0 mg of DNA. The cells were incubated for 3 h in serum-free medium containing DNA and lipofectamine. Then a threefold volume of medium containing 10% FBS was added without removing the transfection mixture, and incubation was done for 22 h followed by staining with X-Gal. The data (mean+S.D.) were analyzed as described in the legend to Figure 1 . Xue et al. (1996) suggested that caspases could be categorized by their ability to cleave CrmA and p35 after studying CED-3, caspase-3, caspase-1, and caspase-2; CED-3 and caspase-3 effectively cleave pro-caspase-3 and baculovirus p35 but not CrmA, caspase-1 effectively cleaves CrmA, and caspase-2 weakly cleaves only baculovirus p35. The preference of caspase-4 and caspase-5 for CrmA rather than baculovirus p35 as a substrate (Figure 2 and Table 1) suggests that these proteases are functionally related to caspase-1, consistent with the findings on structural analysis.
The cowpox virus gene product CrmA is a potent inhibitor of caspase-1 (Ray et al, 1992) and has also been shown to inhibit the induction of apoptosis by various stimuli. CrmA efficiently inhibits granzyme B, but only inhibits caspase-3 and caspase-7 (Mch3/ICE-LAP3/CMH-1) at high concentrations (Quan et al, 1995; FernandesAlnemri et al, 1995) . Here, we have shown that CrmA efficiently inhibits caspase-4 and caspase-5. It was recently reported that a Fas-associated caspase family protease, caspase-8 (MACH/FLICE/Mch5) (Boldin et al, 1996; Muzio et al, 1996; Fernandes-Alnemri et al, 1996) , is a CrmAinhibitable protease . This suggests that caspase-8 is the critical target of CrmA when inhibiting Fas-and TNF-induced apoptosis, because caspase-8 appears to be a protease that is furthest upstream in the caspase cascade. It is not known whether caspase-8 is generally involved in apoptosis. However, since caspase-4 and caspase-5 are also CrmA-inhibitable protease, they may be involved in CrmA-inhibitable physiological apoptosis triggered by a variety of stimuli.
The caspase cascade is implicated in the apoptotic cell death pathway (Enari et al, 1996; Shimizu et al, 1996) . In Fas-mediated apoptosis, caspase-1(-like) proteases seem to act downstream of caspase-8 and/or Mch-4 (caspase-10) and upstream of caspase-3(-like) protease (Enari et al, 1996) . We have recently shown that a caspase-4(-like) protease is involved in Fas-mediated apoptosis, probably by transducing a death signal directly to caspase-3(-like) proteases (Kamada et al, 1997) . Since caspase-4 and caspase-5 cleave pro-caspase-3 to release p12 but not p17, both of which are components of active caspase-3, the generation of p17 might be mediated by other members of caspase family. Alternatively, the release of p12 might lead to auto-activation of caspase-3. In vitro cleavage of pro-caspase-3 by caspase-5 suggests that caspase-5 as well as caspase-1 and caspase-4 might be involved in physiological apoptotic cell death by activating caspase-3(-like) proteases. Thus, multiple protease cascade pathways might exist to activate caspase-3(-like) proteases, one of the executioner protease
Materials and Methods

Cell culture
Rat-1 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Transfection was performed using Lipofectamine (Life Technologies) according to the manufacturer's instructions. For analysis of bgalactosidase expression, cells were rinsed once with phosphatebuffered saline (PBS), fixed with 1% glutaraldehyde for 5 min, rinsed twice with PBS, and stained in X-Gal buffer (0.5 mg/ml 5-bromo-4-chloro-3-indoxyl b-galactoside, 3 mM K 3 Fe(CN) 6 , 3 mM K 4 Fe(CN) 6 -3H20, 1 mM MgCl 2 , 10 mM KCl, 0.1% Triton X-100 in 0.1 M sodium phosphate buffer [pH 7.5]) (Miura et al, 1993) at 378C for 3 h.
Construction of plasmids
To construct expression plasmids, PCR was carried out using the cDNAs of caspase-1, caspase-4, and caspase-5 as templates. The following PCR primers were used: for human caspase-1, C1-5 (5'-CGGTCGACAGCCATGGCCGACAAGGTCCTG-3') and C1-3 (5'-CGGGTACCCAATGTCCTGGGAAGAGGTAGAA-3'); and for human caspase-4, C4-5 (5'-CGGTCGACCCCTATGGCAGAAGGCAACCAC-3') and C4-3 (5'-CGGGTACCCAATTGCCAGGAAAGAGGTAGAA-3'); and for human caspase-5, C5-5 (5'-CGGGTACCAGCTATGTT-CAAAGGTA-3') and C5-3 (5'-CGGGTACCCAATTGCCAGGAAA-GAG-3'). The C1-5 and C4-5 primers had a SalI at the 5' end, while the C1-3, C4-3, C5-5, and C5-3 primers had a KpnI site at their 5' end. The amplified human caspase-1 and caspase-4 fragments and the caspase-5 fragment were respectively cloned into SalI-KpnI sites and the KpnI site of pactbGal, which possesses the chicken b-actin promoter (Maekawa et al, 1991) to generate pcas-1-lacZ, pcas-4-lacZ and pcas-5-lacZ, respectively. In these constructs, the sequences coding for the proteases were joined in-frame to the amino terminal of b-galactosidase. The same fragments were also cloned into SalI-KpnI sites and the KpnI site of pBluescript SK(7) (Stratagene) and sequenced.
The crmA gene was isolated as a 1.4 kb EcoRI fragment by digestion of plasmid p996 (Pickup et al, 1986) and was inserted into the EcoRI site of the pUC-CAGGS vector (Niwa et al, 1991) , generating pCAG-crmA.
Puri®cation of recombinant His 6 -tagged proteases DNA sequences encoding the 105 ± 377th amino acid residue of caspase-4, 122 ± 418th amino acid residue of caspase-5 and 29 ± 277th amino acid residue of caspase-3 were amplified by PCR and subcloned into the E. coli expression vector pRSET A (Invitrogen), in which the protease sequences were placed under the control of the T7 promoter and joined in-frame to sequences encoding an N-terminal fusion peptide, which includes an ATG translation initiation codon and the sequence for six successive histidine residues that function as a metal-binding domain in the translated proteins. The resultant plasmids (pHiscas4, pHiscas5 and pHiscas3) were transformed into E. coli strain JM109. Induction of recombinant His 6 -tagged proteases was achieved according to the manufacturer's instructions. Cells were harvested and recombinant proteases were purified essentially as described elsewhere (Lippke et al, 1996) . Fractions showing proteolytic activity in an in vitro cleavage assay (described below) were pooled and dialyzed against buffer A (50 mM HEPES, 0.1 M NaCl, 10% (v/v) glycerol, pH 7.5) to remove excess imidazole and were stored at 7808C. The purity of the proteins thus obtained was greater than 80% for His-caspase-4 or His-caspase-5, and approximately 20% for His-caspase-3, as estimated by Coomassie blue staining.
Puri®cation of His 6 -tagged CrmA protein crmA DNA containing the entire coding region was amplified by PCR using the p996 plasmid (Pickup et al, 1986) as a template and two primers, HisCrm5 (5'-CGCTCGAGGAATGGATATCTTCAGG) and HisCrm3 (5'-CGGAATTCTTAATTAGTTGTTGG), encompassing the initiation and termination codons of CrmA, respectively. HisCrm5 had an XhoI site at the 5' end and HisCrm3 had an EcoRI site. The amplified fragment was subcloned into the XhoI-EcoRI sites of pRSET C to generate pHiscrmA. Expression of His 6 -tagged CrmA was achieved according to the manufacturer's instructions. Cells were lyzed by sonication in a buffer containing 20 mM sodium phosphate (pH 7.8) and 0.5 M NaCl, after which the lysates were cleared by centrifugation. Then the supernatants containing soluble His-CrmA were loaded onto a 1 ml nickel-NTA column (Qiagen) and washed extensively with 20 mM sodium phosphate (pH 6.0) and 0.5 M NaCl. His-CrmA protein was eluted with 100 ± 200 mM imidazole in 20 mM sodium phosphate (pH 7.8) and 0.5 M NaCl, and was found to elute at approximately 200 mM imidazole. It was dialyzed against buffer A to remove excess imidazole and stored at 7808C. The protein thus obtained showed greater than 90% purity by Coomassie blue staining.
In vitro cleavage assay
To construct an expression plasmid for His 6 -tagged baculovirus p35, the 1 kb NdeI p35 fragment containing entire coding region was blunt-ended and inserted into the PvuII site of pRSET A, generating pHisp35. To substitute Cys 163 for Ser and Arg 207 for Glu in caspase-3, a PCR-based method was used. The final PCR product was cloned into the EcoRI site of pBluescript SK (7) and sequenced. The same fragment encoding caspase-3 containing active site mutations at both p17 and p12 subunits was subcloned into pRSET A to generate pHiscas3 m . 35 S-methionine-labeled His 6 -tagged CrmA, p35 and mutant pro-caspase-3 were prepared for in vitro cleavage assays using expression constructs (pHiscrmA, pHisp35, and pHiscas3 m ) and a TNT T7 coupled in vitro transcription and translation system (Promega) according to the manufacturer's instructions.
35 S-methionine-labeled proteins were purified essentially as described elsewhere (Tewari et al, 1995a) and stored at 7808C until use. Recombinant caspase-4, caspase-5, and caspase-3 with or without His-CrmA were preincubated in 20 ml of buffer A supplemented with 20 mM dithiothreitol at room temperature for 15 min. Reactions were initiated by addition of 20 ml of 35 S-methionine-labeled proteins and incubation was done at 378C for 3.5 h. The reactions were stopped by the addition of SDS ± PAGE sample buffer and cleaved products were analyzed by 15% SDS ± PAGE.
